TAG:
QuidelOrtho
For IVD Companies, Tariff Refunds May Be a Long Haul
By Mark Terry | From the Volume XXXIII, No. 5 – April 13, 2026 Issue
Following the US Supreme Court’s decision declaring certain tariffs illegal, the diagnostics industry has entered a murky period regarding potential refunds. For in vitro diagnostics (IVD) manufacturers who paid these tariffs under policies f…
Global IVD Woes in China Should Resonate with US Labs
By Mark Terry | From the Volume XXXIII, No. 3 – March 2, 2026 Issue
In vitro diagnostics (IVD) companies reported a mix of overall growth, with many noting continuing challenges in their diagnostics divisions for recent quarterly financial results. Thermo Fisher Scientific, QuidelOrtho, and Danaher reported the…
Reforms in China Affect IVD Companies’ Q3 2025 Earnings
By Mark Terry | From the Volume XXXII, No. 16 – November 17, 2025 Issue
Most of the in vitro diagnostics (IVD) manufacturers that serve clinical laboratories worldwide reported facing financial “headwinds” in the China IVD market that affected their third-quarter performance. This was due to policy changes in the country…
October 6, 2025, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 14 – October 6, 2025 Issue
Bloomberg News has reported that Siemens Healthineers is potentially exploring a sale of its diagnostics division. Several large private equity firms have held early talks with Siemens, including Blackstone, CVC Capital Partners, and KKR & Co., according to Bloomberg. Sourc…
2025 Ranking of the World’s Top 13 IVD Corporations
By Mark Terry | From the Volume XXXII, No. 13 – September 15, 2025 Issue
BASED ON PUBLICLY-REPORTED 2024 DIAGNOSTICS-RELATED REVENUE, four in vitro diagnostics (IVD) companies continue to dominate the global market, as they have for the last two years: Thermo Fisher Scientific, Roche, Danaher, and Abbott Laboratories. The top 13 companies …
Despite Trade Tariffs, IVD Firms Report Upbeat Earnings
By Mark Terry | From the Volume XXXII, No. 12 – August 25, 2025 Issue
LEADING IN VITRO DIAGNOSTICS (IVD) COMPANIES RECENTLY REPORTED POSITIVE QUARTERLY FINANCIALS despite swirling concerns about trade tariffs and cuts to US federal research grants. It’s not yet clear what the long-term effect of tariffs’ will be on IVD manu…
July 14, 2025, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 10 – July 14, 2025 Issue
Clinical laboratories across the country that have not prepared for the potential of increased measles testing may want to consider doing so. On July 7, The Washington Post reported that US measles cases had reached a 33-year high, based on data collected by the Johns Hopkins Center for…
Global IVD Companies Issue Fourth Quarter 2024 Earnings
By Robert Michel | From the Volume XXXII, No. 5 – March 31, 2025 Issue
OVERALL, IN VITRO DIAGNOSTICS (IVD) COMPANIES REPORTED A MIXED BAG of financial results for the quarter ending Dec. 31, 2024, with Becton, Dickinson and Company, Abbott Laboratories, and Siemens Healthineers showing the most momentum based on r…
March 10, 2025, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 4 – March 10, 2025 Issue
Genetic testing is coming to a cruise ship! The New York Post reported that the MV Narrative will be launched this year by Storylines. CruiseCritic describes this vessel as “a residential ship that will create a floating ‘neighborhood’ for a community of up to 1,000 people, including f…
January 27, 2025, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 2 – January 27, 2025 Issue
On Jan. 16, 2025, Paul Mango died at the age of 65. With his passing, the profession of laboratory medicine lost an ally and a friend. In the mid-1990s, while at the Institute for Transfusion Medicine in Pittsburgh, Mango convinced the CEOs of 40 hospitals to collaborate and create t…
CURRENT ISSUE
Volume XXXIII, No. 7 – May 26, 2026
Momentum is building on Capitol Hill to pass the RESULTS Act, which would stave off drastic 15% reimbursement cuts under PAMA. Advocates seek lobbying help from clinical labs and anatomic pathology practices. Also, The Dark Report examines Roche’s deal to acquire PathAI.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized